Peripubertal hyperinsulinemia upregulates phosphatidylinositol 3-kinase/Akt pathway in rat ovaries

Reproductive Sciences

Volumn 15, Issue 3, 2008, Pages 274-284

  Chakrabarty, Shilla ^a   Nagamani, Manubai ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Hyperinsulinemia; Insulin signaling; Ovary; Peripuberty

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HYPERINSULINEMIA; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; INSULIN SENSITIVITY; NONHUMAN; OVARY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PUBERTY; RAT; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; ESTROUS CYCLE; FEMALE; GLYCOGEN SYNTHASE KINASE 3; HYPERINSULINISM; IMMUNOHISTOCHEMISTRY; INSULIN; MICROFILAMENT PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; OVARY; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; SEXUAL MATURATION; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 42249099445     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719108316389     Document Type: Article

References (33)

1. Guzick DS Polycystic ovary syndrome. Obstet Gynecol. 2004 ; 103: 181-193.
2. Norman RJ, Wu R., Stankiewicz MT Polycystic ovary syndrome. Med J Aust. 2004 ; 180: 132-137.
3. Burghen GA, Givens JR, Kitabchi AE Correlation of hyperandrogenism and hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab. 1980 ; 50: 113-116.
4. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997 ; 18: 774-800.
5. Venkatesan AM, Dunaif A., Corbould A. Insulin resistance in polycystic ovary syndrome: progress and paradoxes. Recent Prog Horm Res. 2001 ; 56: 295-308.
6. Dunaif A., Segal KR, Shelley DR, Green G., Dobrjansky A., Licholai T. Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes. 1992 ; 41: 1257-1266.
7. Ciaraldi TP, el-Roeiy A., Madar Z., Reichart D., Olefsky JM, Yen SS Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. J Clin Endocrinol Metab. 1992 ; 75: 577-583.
8. Dunaif A., Book CB, Scheneker E., Tang Z. Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome.J Clin Invest. 1995 ; 96: 801-810.
9. Dunaif A., Wu X., Lee A., Diamanti-Kandarakis E. Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). Am J Physiol Endocrinol Metab. 2001 ; 281: E392 - E399.
10. Corbould A., Kim YB, Youngren JF, et al. Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling. Am J Physiol Endocrinol Metab. 2005 ; 288: E1047 - E1054.
11. Poretsky L. Commentary: Polycystic ovary syndrome- increased or preserved ovarian sensitivity to insulin? J Clin Endocrinol Metab. 2006 ; 91: 2859-2860.
12. Nagamani M., Stuart CA Specific binding sites for insulin-like growth factor I in the ovarian stroma of women with polycystic ovarian disease and stromal hyperthecosis. Am J Obstet Gynecol. 1990 ; 163: 1992-1997.
13. Poretsky L., Smith D., Seibel M., Pazianos A., Moses AC, Flier JS Specific insulin binding sites in the human ovary. J Clin Endocrinol Metab. 1984 ; 59: 809-811.
14. Nestler JE, Jakubowicz DJ, de Vargas AF, Brik C., Quintero N., Medina F. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositol-glycan mediators as the signal transduction system. J Clin Endocrinol Metab. 1998 ; 83: 2001-2005.
15. Chakrabarty S., Miller BT, Collins TJ, Nagamani M. Ovarian dysfunction in peripubertal hyperinsulinemia. J Soc Gynecol Investig. 2006 ; 13: 122-129.
16. Saltiel AR, Kahn CR Insulin signaling and the regulation of glucose and lipid metabolism. Nature. 2001 ; 414: 799-806.
17. Saltiel AR, Pessin JE Insulin signaling pathways in time and space. Trends Cell Biol. 2002 ; 12: 65-71.
18. Sasaoka T., Rose DW, Jhun BH, Saltiel AR, Draznin B., Olefsky JM Evidence for a functional role of Shc proteins in mitogenic signaling induced by insulin, insulin-like growth factor-1, and epidermal growth factor. JBiol Chem. 1994 ; 269: 13689-13694.
19. Chatterjee-Chakrabarty S., Miller BT, Collins TJ, Nagamani M. Adverse effects of methylphenidate on the reproductive axis of adolescent female rats. Fertil Steril. 2005 ; 84: 1131-1138.
20. Juan CC, Shen YW, Chien Y., Lin YJ, Chang SF, Ho LT Insulin infusion induces endothelin-1-dependent hypertension in rats. Am J Physiol Endocrinol Metab. 2004 ; 287: E948 - E954.
21. Juan CC, Fang VS, Kwok CF, Perng JC, Chou YC, Ho LT Exogenous hyperinsulinemia causes insulin resistance, hyperendothelinemia and subsequent hypertension in rats. Metabolism. 1999 ; 48: 465-471.
22. Boucher J., Masri B., Daviaud D., et al. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology. 2005 ; 146: 1764-1771.
23. Chatterjee S., Park ES, Soloff MS Proliferation of DU145 prostate cancer cells is inhibited by suppressing insulin-like growth factor binding protein-2. Int J Urol. 2004 ; 11: 876-884.
24. Chakrabarty S., Kondratick L. Insulin-like growth factor binding protein-2 stimulates proliferation and activates multiple cascades of the mitogen-activated protein kinase pathways in NIH-OVCAR3 human epithelial ovarian cancer cells. Cancer Biol Ther. 2006 ; 5: 189-197.
25. Laemmli UK Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 ; 227: 680-685.
26. Chatterjee S., Gangula PR, Dong YL, Yallampalli C. Immunocytochemical localization of nitric oxide synthase-III in reproductive organs of female rats during the oestrus cycle. Histochem J. 1996 ; 28: 715-723.
27. Fang L., Chatterjee S., Dong YL, Gangula PR, Yallampalli C. Immunohistochemical localization of constitutive and inducible cyclo-oxygenases in rat uterus during the oestrous cycle and pregnancy. Histochem J. 1998 ; 30: 383-391.
28. O'Driscoll SW, Marx RG, Beaton DE, Miura Y., Gallay SH, Fitzsimmons JS Validation of a simple histological-histochemical cartilage scoring system. Tissue Eng. 2001 ; 7: 313-320.
29. Diamanti-Kandarakis E., Papavassiliou AG Molecular mechanisms of insulin resistance in polycystic ovary syndrome. Trends Mol Med. 2006 ; 12: 324-332.
30. White MF Insulin signaling pathway. Science. 2003 ; 302: 1710-1711.
31. Lawlor MA, Alessi DR PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? J Cell Sci. 2001 ; 114: 2903-2910.
32. Johnson AL, Bridgham JT, Swenson JA Activation of the Akt/protein kinase B signaling pathway is associated with granulosa cell survival. Biol Reprod. 2001 ; 64: 1566-1574.
33. Munir I., Yen HW, Geller DH, et al. Insulin augmentation of 17 alpha-hydroxylase activity is mediated by phosphatidyl inositol 3-kinase but not extracellular signal-regulated kinase-1/2 in human ovarian theca cells. Endocrinology. 2004 ; 145: 175-183.